Literature DB >> 8900410

Characterization of the complete genomic structure of human thromboxane synthase gene and functional analysis of its promoter.

R Tazawa1, E D Green, K Ohashi, K K Wu, L H Wang.   

Abstract

Thromboxane A2 (TXA) is a potent vasoconstrictor and mediator of platelet aggregation. Thromboxane synthase (TXAS), which catalyzes the biosynthesis of TXA, is a member of the cytochrome P450 superfamily. We report here the complete genomic structure of the human TXAS gene. The gene contains 13 exons and is 193 kb long, the largest P450 gene ever isolated. The physical localization of the TXAS gene on the genetic map of human chromosome 7 was established. A major transcription start site is located at a motif similar to the initiator element where the transcription factor TFII-I binds. We have sequenced up to 1.6 kb of the 5'-flanking region of the TXAS gene and characterized the promoter activity in a human megakaryocyte cell line and endothelial cells. Our results demonstrated that the nucleotides -248/+137 relative to the major transcription start site conferred a full promoter activity of the TXAS gene. This region was regulated negatively by cis-elements located between -1562 and -248. Moreover, the regions outside -1562/+137 might control tissue-specific TXAS expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900410     DOI: 10.1006/abbi.1996.0464

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Functional analysis of human thromboxane synthase polymorphic variants.

Authors:  Chung-Ying K Chen; Elizabeth M Poole; Cornelia M Ulrich; Richard J Kulmacz; Lee-Ho Wang
Journal:  Pharmacogenet Genomics       Date:  2012-09       Impact factor: 2.089

2.  Interaction of Huntington disease protein with transcriptional activator Sp1.

Authors:  Shi-Hua Li; Anna L Cheng; Hui Zhou; Suzanne Lam; Manjula Rao; He Li; Xiao-Jiang Li
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

3.  Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome.

Authors:  A W Y Chung; H H C Yang; C van Breemen
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.